NTRA (Natera Corp) שולי הרווח הגולמי

סמל תאגידי ולוגו של Natera Inc (NTRA)

Natera, Inc. (NTRA) growth is fundamentally driven by unique cell-free DNA analysis and an extensive array of genomic data. This trend is captured by the gross margin dynamics on the GURU.Markets chart, where the parameter is 64.50. Aggressive management drives business expansion through clinical trials, while profit stability is guaranteed by structural demand in reproductive medicine, which remains indifferent to general economic cycles.

NTRA (Natera, Inc.) היסטוריית שולי רווח גולמי מ-04.07.2022 עד 20.11.2026

פילוחי מדדים פיננסיים ומדדי שוק עבור natera.com (NTRA)

- שער מניה ותחזית מחירי מומחים:
- מדדי הערכת שווי שוק של העסק:
ניתוח בסיסי של החברה:Natera
מוצרים מיוצרים של Natera, Inc.

For Natera, Inc. (NTRA), which holds unique patents in the field of cell-free DNA analysis, the gross margin reflects the monetization efficiency of its high-tech tests. This metric is calculated as the difference between total revenue and direct production costs, expressed as a percentage of revenue. By analyzing the gross profit percentage, an investor can assess the impact of the company's pricing power on operational efficiency. The stability of this metric confirms the business's resilience to rising costs.